Approximately 6% of patients diagnosed with non-Hodgkin’s lymphoma have mantle cell lymphoma (MCL), which is typically associated with a bad prognosis. At this point, there is not a standard of care for MCL, and “optimal” treatment is dependent on where a patient is being treated, Myron S. Czuczman, MD, suggests.
Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.
For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.
You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.
For more information on CAR T-cells and T-cell lymphoma click here.
Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.
